Malaysian Genomics Resource Centre Bhd.
MMYX:MGRC0.34
MYR
0.00
(0.00%)
ISIN
MYQ0155OO000
Return %
Stock
S&P 500
1Y
67.50
14.20
3Y
-33.00
81.12
5Y
-87.16
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Yien Hung Leong
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Petaling Jaya Malaysia
- IPO Date
- Sep 8, 2010
- Website
- mgrc.com.my
- Similar Companies
- Business
- Malaysian Genomics Resource Centre Berhad is a Malaysia-based biotechnology and biopharmaceutical company that provides genomics sequencing, bioinformatics analysis, genetic screening diagnostics, and cell-based regenerative therapies. The company operates through three core business segments: Genomics and Bioinformatics Services, Biopharmaceutical and Cell Therapy Solutions, and Healthcare Products and Distribution. Its genomics and diagnostics portfolio includes high-throughput next-generation sequencing (NGS); whole-genome, exome, and transcriptome sequencing; metagenomics and agricultural profiling; bioinformatics pipeline processing and data analytics; and proprietary predictive genetic screening tests marketed under the Dtect brand, which encompass screening panels for oncology, cardiology, metabolic disorders, pharmacogenomics, pediatric health, and lifestyle wellness. Its biopharmaceutical and cellular therapy operations utilize certified current Good Manufacturing Practice (cGMP) cleanroom laboratories to manufacture and supply advanced cellular therapeutics, including Chimeric Antigen Receptor (CAR) T-cell immunotherapies for hematological and solid tumor oncology treatments; Natural Killer (NK) cell therapies; Mesenchymal Stem Cells (MSCs) for regenerative medicine; and cell-free exosome formulations for tissue regeneration, dermatology, and aesthetic medicine. In addition, the company markets and distributes finished exosome-infused cosmeceuticals, therapeutic skincare lines, wellness supplements, and clinical pathology tests. Malaysian Genomics Resource Centre serves tertiary hospitals, specialist medical centers, aesthetic and wellness clinics, life sciences researchers, academic institutions, pharmaceutical developers, and direct consumers across Malaysia, Southeast Asia, the Middle East, and North America. In recent developments, the company has expanded its regional presence through strategic commercialization partnerships to distribute CAR T-cell therapies across ASEAN markets; forged cross-border distribution alliances with healthcare and pharmaceutical networks in Indonesia, Thailand, and the Middle East for its Dtect screening panels and exosome skincare products; entered agreements to deploy veterinary and agricultural genomics solutions; and upgraded its cGMP cleanroom manufacturing infrastructure to expand contract development and manufacturing organization (CDMO) services for regenerative and cell-based therapeutics. Founded in 2004, Malaysian Genomics Resource Centre Berhad is headquartered in Petaling Jaya, Selangor, Malaysia.